Evidence map›Paper›PMID 29066892›Full record

ArticleInternational journal of nanomedicine2017

Bioresponsive cancer-targeted polysaccharide nanosystem to inhibit angiogenesis.

Fang Yang, Xueyang Fang, Wenting Jiang, Tianfeng Chen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of nanomedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Fang YangDepartment of Chemistry, Jinan University, Guangzhou, China.
Xueyang FangDepartment of Chemistry, Jinan University, Guangzhou, China.
Wenting JiangDepartment of Chemistry, Jinan University, Guangzhou, China.
Tianfeng ChenDepartment of Chemistry, Jinan University, Guangzhou, China.
Jinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With many desirable features, such as being more effective and having multiple effects, antiangiogenesis has become one of the promising cancer treatments. The aim of this study was to design and synthesize a new targeted bioresponsive nanosystem with antiangiogenesis properties. The mUPR@Ru(POP) nanosystem was constructed by the polymerization of

Indexed as

Angiogenesis InhibitorsAnimalsAntineoplastic AgentsApoptosisCell MovementChick EmbryoChorioallantoic MembraneHumansHuman Umbilical Vein Endothelial CellsHydrogen-Ion ConcentrationNanostructuresNeovascularization, PathologicOligopeptidesPolysaccharidesVascular Endothelial Growth Factor AAngiogenesis InhibitorsAntineoplastic Agentsarginyl-glycyl-aspartic acidOligopeptidesPolysaccharidesVascular Endothelial Growth Factor Aantiangiogenesisbioresponsivecancer-targetedpolysaccharide nanosystem

Identifiers

PMID29066892
PMCPMC5644532
OpenAlexW2762677124

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.